Cerebral blood flow effects of acute intravenous heroin administration

Markus Kosel, Roger S. Noss, Robert Hämmig, Peter Wielepp, Petra Bundeli, Rebeca Heidbreder, Jane A. Kinser, Rudolf Brenneisen, Hans Ulrich Fisch, Sarah Kayser, Thomas E. Schlaepfer

Research output: Contribution to journalArticle

Abstract

We examined acute effects of intravenous diacetylmorphine (heroin) administration - which induces a characteristic biphasic response: A short rush-sensation associated with intense pleasurable feelings followed by a subjectively different period of euphoria on cerebral blood flow. This was assessed in nine male heroin dependent patients participating in a heroin maintenance program in a setting resembling everyday pattern of heroin abuse. 99mTc-HMPAO was administered 45 s (rush) and 15 min (euphoria) after administration of i.v. heroin and 45 s after administration of saline (placebo). Plasma concentration of diacetylmorphine and its metabolites were measured with high-pressure liquid chromatography (HPLC). Compared to the euphoria condition, rush was associated with blood flow increase in the left posterior cerebellar lobe, left anterior cingulate gyrus and right precuneus. Our results are in line with recent reports indicating that the cerebellum is an important component in functional brain systems subserving sensory and motor integration, learning, modulation of affect, motivation and social behaviour, which all play important roles in reinforcing properties of opioids.

Original languageEnglish (US)
Pages (from-to)278-285
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume18
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Cerebrovascular Circulation
Heroin
Intravenous Administration
Technetium Tc 99m Exametazime
Heroin Dependence
Parietal Lobe
Social Behavior
Gyrus Cinguli
Cerebellum
Opioid Analgesics
Motivation
Emotions
High Pressure Liquid Chromatography
Placebos
Maintenance
Learning
Brain

Keywords

  • Addiction
  • Cerebellum
  • Diacetylmorphine
  • Heroin
  • Opioid
  • Single photon emission computed tomography

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Pharmacology
  • Psychology(all)

Cite this

Cerebral blood flow effects of acute intravenous heroin administration. / Kosel, Markus; Noss, Roger S.; Hämmig, Robert; Wielepp, Peter; Bundeli, Petra; Heidbreder, Rebeca; Kinser, Jane A.; Brenneisen, Rudolf; Fisch, Hans Ulrich; Kayser, Sarah; Schlaepfer, Thomas E.

In: European Neuropsychopharmacology, Vol. 18, No. 4, 04.2008, p. 278-285.

Research output: Contribution to journalArticle

Kosel, M, Noss, RS, Hämmig, R, Wielepp, P, Bundeli, P, Heidbreder, R, Kinser, JA, Brenneisen, R, Fisch, HU, Kayser, S & Schlaepfer, TE 2008, 'Cerebral blood flow effects of acute intravenous heroin administration', European Neuropsychopharmacology, vol. 18, no. 4, pp. 278-285. https://doi.org/10.1016/j.euroneuro.2007.11.007
Kosel, Markus ; Noss, Roger S. ; Hämmig, Robert ; Wielepp, Peter ; Bundeli, Petra ; Heidbreder, Rebeca ; Kinser, Jane A. ; Brenneisen, Rudolf ; Fisch, Hans Ulrich ; Kayser, Sarah ; Schlaepfer, Thomas E. / Cerebral blood flow effects of acute intravenous heroin administration. In: European Neuropsychopharmacology. 2008 ; Vol. 18, No. 4. pp. 278-285.
@article{74ad0e46a10848b6909f6f29b5a58abc,
title = "Cerebral blood flow effects of acute intravenous heroin administration",
abstract = "We examined acute effects of intravenous diacetylmorphine (heroin) administration - which induces a characteristic biphasic response: A short rush-sensation associated with intense pleasurable feelings followed by a subjectively different period of euphoria on cerebral blood flow. This was assessed in nine male heroin dependent patients participating in a heroin maintenance program in a setting resembling everyday pattern of heroin abuse. 99mTc-HMPAO was administered 45 s (rush) and 15 min (euphoria) after administration of i.v. heroin and 45 s after administration of saline (placebo). Plasma concentration of diacetylmorphine and its metabolites were measured with high-pressure liquid chromatography (HPLC). Compared to the euphoria condition, rush was associated with blood flow increase in the left posterior cerebellar lobe, left anterior cingulate gyrus and right precuneus. Our results are in line with recent reports indicating that the cerebellum is an important component in functional brain systems subserving sensory and motor integration, learning, modulation of affect, motivation and social behaviour, which all play important roles in reinforcing properties of opioids.",
keywords = "Addiction, Cerebellum, Diacetylmorphine, Heroin, Opioid, Single photon emission computed tomography",
author = "Markus Kosel and Noss, {Roger S.} and Robert H{\"a}mmig and Peter Wielepp and Petra Bundeli and Rebeca Heidbreder and Kinser, {Jane A.} and Rudolf Brenneisen and Fisch, {Hans Ulrich} and Sarah Kayser and Schlaepfer, {Thomas E.}",
year = "2008",
month = "4",
doi = "10.1016/j.euroneuro.2007.11.007",
language = "English (US)",
volume = "18",
pages = "278--285",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Cerebral blood flow effects of acute intravenous heroin administration

AU - Kosel, Markus

AU - Noss, Roger S.

AU - Hämmig, Robert

AU - Wielepp, Peter

AU - Bundeli, Petra

AU - Heidbreder, Rebeca

AU - Kinser, Jane A.

AU - Brenneisen, Rudolf

AU - Fisch, Hans Ulrich

AU - Kayser, Sarah

AU - Schlaepfer, Thomas E.

PY - 2008/4

Y1 - 2008/4

N2 - We examined acute effects of intravenous diacetylmorphine (heroin) administration - which induces a characteristic biphasic response: A short rush-sensation associated with intense pleasurable feelings followed by a subjectively different period of euphoria on cerebral blood flow. This was assessed in nine male heroin dependent patients participating in a heroin maintenance program in a setting resembling everyday pattern of heroin abuse. 99mTc-HMPAO was administered 45 s (rush) and 15 min (euphoria) after administration of i.v. heroin and 45 s after administration of saline (placebo). Plasma concentration of diacetylmorphine and its metabolites were measured with high-pressure liquid chromatography (HPLC). Compared to the euphoria condition, rush was associated with blood flow increase in the left posterior cerebellar lobe, left anterior cingulate gyrus and right precuneus. Our results are in line with recent reports indicating that the cerebellum is an important component in functional brain systems subserving sensory and motor integration, learning, modulation of affect, motivation and social behaviour, which all play important roles in reinforcing properties of opioids.

AB - We examined acute effects of intravenous diacetylmorphine (heroin) administration - which induces a characteristic biphasic response: A short rush-sensation associated with intense pleasurable feelings followed by a subjectively different period of euphoria on cerebral blood flow. This was assessed in nine male heroin dependent patients participating in a heroin maintenance program in a setting resembling everyday pattern of heroin abuse. 99mTc-HMPAO was administered 45 s (rush) and 15 min (euphoria) after administration of i.v. heroin and 45 s after administration of saline (placebo). Plasma concentration of diacetylmorphine and its metabolites were measured with high-pressure liquid chromatography (HPLC). Compared to the euphoria condition, rush was associated with blood flow increase in the left posterior cerebellar lobe, left anterior cingulate gyrus and right precuneus. Our results are in line with recent reports indicating that the cerebellum is an important component in functional brain systems subserving sensory and motor integration, learning, modulation of affect, motivation and social behaviour, which all play important roles in reinforcing properties of opioids.

KW - Addiction

KW - Cerebellum

KW - Diacetylmorphine

KW - Heroin

KW - Opioid

KW - Single photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=39149093957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149093957&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2007.11.007

DO - 10.1016/j.euroneuro.2007.11.007

M3 - Article

C2 - 18207374

AN - SCOPUS:39149093957

VL - 18

SP - 278

EP - 285

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 4

ER -